On Wednesday 11th October 2023, Prof. Camilla Forsberg from University of California, delivered an inspiring public lecture on stem cell and regenerative medicine at the university. The presentation was dubbed; ‘For the love of blood: Hematopoietic stem cells functions through the lifespan. Prof. Forsberg who is also the Director of the Institute of for the Biology of Stem Cells (IBSC), is globally recognised for her pioneering research in stem cell in biology and regenerative medicine.
The lecture provided valuable insights into the latest advancement of hematopoietic stem cell research and their potential for transforming the landscape of clinical medicine.
Prof. Forsberg was earlier received by Prof. Alfred Orina, the DVC, Research and Technology Development (RTD), on behalf of the VC Prof. Benedict Mutua. Prof. Orina was accompanied by Prof. Paul Wambua, DVC Institutional Management and Enterprise, Prof. Francis Gatheri, Executive Dean FAST and Dr. James Nyariki, Senior Lecturer, Department of Biochemistry and Biotechnology.
Prof. Orina called on the visiting professor to lead in research collaboration between University of California and TU-K.
Prof Wambua noted that the two institutions would embark on formalising the collaborative efforts through an MoU.
In her lecture, Prof. Forsberg explained the fundamental role of hematopoietic stem cells in the human body. She noted that these unique cells have the remarkable ability to give rise to all blood cell types, making them indispensable for the body continuous replenishment of the blood cells.
The presentation focused on the potential application in treating a wide range of diseases, including; leukemia, lymphoma, anemia and various genetic blood disorders.
Prof. Forsberg heighted several clinical trials and case studies that demonstrated promising results of hematopoietic stem cell therapies. These therapies have enabled patients with life-threatening conditions to receive to receive life-saving treatments that were once considered out of reach. She emphasised the immense potential of hematopoietic stem cell transplantation in personalised medicine, allowing tailored treatment for individual patients.
The Institute for the Biology of Stem Cells (IBSC) encompasses research, training, and facilities. They promote stem cell research and bring in funding to institutions for accessibility. The Institution also runs training programs that are intended to fund, educate and connect stem cell researchers.
